Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) FCF Margin (2016 - 2020)

Historic FCF Margin for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Q2 2020 value amounting to 77.11%.

  • Avadel Pharmaceuticals' FCF Margin fell 688700.0% to 77.11% in Q2 2020 from the same period last year, while for Mar 2021 it was 600.88%, marking a year-over-year decrease of 5486200.0%. This contributed to the annual value of 433.12% for FY2024, which is N/A changed from last year.
  • Avadel Pharmaceuticals' FCF Margin amounted to 77.11% in Q2 2020, which was down 688700.0% from 95.04% recorded in Q1 2020.
  • In the past 5 years, Avadel Pharmaceuticals' FCF Margin ranged from a high of 54.97% in Q1 2016 and a low of 129.2% during Q1 2019
  • In the last 5 years, Avadel Pharmaceuticals' FCF Margin had a median value of 46.03% in 2017 and averaged 39.87%.
  • In the last 5 years, Avadel Pharmaceuticals' FCF Margin plummeted by -124655300bps in 2016 and then soared by 601600bps in 2019.
  • Avadel Pharmaceuticals' FCF Margin (Quarter) stood at 17.5% in 2016, then plummeted by -328bps to 39.92% in 2017, then plummeted by -194bps to 117.29% in 2018, then skyrocketed by 36bps to 75.06% in 2019, then fell by -3bps to 77.11% in 2020.
  • Its FCF Margin was 77.11% in Q2 2020, compared to 95.04% in Q1 2020 and 75.06% in Q4 2019.